跳至主要内容
临床试验/JPRN-UMIN000016401
JPRN-UMIN000016401已完成未知

Evaluation of safety and efficacy of tranilast in preventing graft-versus-host disease after allogeneic hematopoietic stem cell transplantation - Tranilast in preventing GVHD after allogeneic HSCT

Keio University School of Medicine0 个研究点目标入组 40 人开始时间: 2015年2月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Poorly controlled diabetes even with insulin treatment 2) Poorly controlled hypertension 3) Poorly controlled active infection 4) Not expecting 3 months or longer survival due to refractory disease or infection 5) Requring immediate tapering of immunosuppressant because of high risk of disease replapse 6) Active disease infiltration of central nervous system 7) Active double cancer 8) Pregnant or nursing patients 9) Poorly controlled psychiatric disorder 10) History of hypersensitivity or moderate or greater adverse events due to tranilast, cyclosporine, tacrolimus, and methotrexate.

研究者

相似试验